Interleukin-22 as a molecular adjuvant facilitates IL-17-producing CD8 +T cell responses against a HBV DNA vaccine in mice

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 10, 2013, Pages 2133-2141

  Wu, Bing ^a   Zou, Qiang ^a,c   Hu, Yanxin ^a   Wang, Bin ^a,b  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Adjuvant; DNA vaccine; HBV; IL 22; Tcl7

Indexed keywords

CASPASE; CASPASE 3; CASPASE 7; DEVD AMINOLUCIFERIN; LUCIFERASE; LUCIFERIN; REAGENT; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOLUMINESCENCE; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; FREEZE DRYING; HIGH TEMPERATURE PROCEDURES; HUMAN; HUMAN CELL; MOLECULAR IMAGING; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DETERMINATION; PROTEIN INTERACTION; SIGNAL DETECTION;

ADJUVANT; DNA VACCINE; HBV; IL-22; TC17;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; INTERLEUKIN-17; INTERLEUKINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA;

EID: 84885097999     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.26047     Document Type: Article

References (53)

1. Arora D, Arora B, Khetarpal A. Seroprevalence of HIV, HBV, HCV and syphilis in blood donors in Southern Haryana. Indian J Pathol Microbiol 2010;53:308-9; PMID:20551540; http://dx.doi.org/l 0.4103/0377-4929.64295
2. Guo Y, Ren D, He X, Wang F, Jiang L, Song S, He Y, Sun S. A novel mouse model for immunogenic evaluation of human HBV vaccines. Vaccine 2009;27:5692-9; PMID:19615480; http://dx.doi.org/10.1016Zj.vaccine.2009.06.088
3. Takahashi K, Brotman B, Usuda S, Mishiro S, Prince AM. Full-genome sequence analyses of hepatitis B virus (HBV) strains recovered from chimpanzees infected in the wild: implications for an origin of HBV. Virology 2000;267:58-64; PMID: 10648183; http://dx.doi.org/10.1006/viro.1999.0102
4. Chen H, Chuai X, Deng Y, Wen B, Wang W, Xiong S, Ruan L, Tan W. Optimisation of prime-boost immunization in mice using novel protein-based and recombinant vaccinia (Tiantan)-based HBV vaccine. PLoS One 2012;7:e43730; PMID:22970140; http://dx. doi.org/10.1371/jo urnal.pone.0043730
5. Dandri M, Liitgehetmann M, Petersen J. Experimental models and therapeutic approaches for HBV. Semin Immunopathol 2013;35:7-21; PMID:22898798; http://dx.doi.org/10.1007/s00281-012-0335-7
6. Seed CR, Jones NT, Pickworth AM, Graham WR. Two cases of asymptomatic HBV "vaccine breakthrough" infection detected in blood donors screened for HBV DNA. Med J Aust 2012;196:651-2; PMID:22676882; http://dx. doi.org/10.5694/mj all.11589
7. Evans AA, London WT, Gish RG, Cohen C, Block TM. Chronic HBV infection outside treatment guidelines: is treatment needed? Antivir Ther 2013;18:229-35; PMID:22914436; http://dx.doi.org/10.3851/IMP2325
8. Changotra H, Sehajpal PK. Quantitative detection of serum HBV DNA levels employing a new S gene based cPCR assay. Arch Virol 2005;150:481-91; PMID: 15747164; http://dx.doi.org/10.1007/s00705-004-0432-6
9. Zou Q, Wu B, He X, Zhang Y, Kang Y, Jin J, Xu H, Liu H, Wang B. Increasing a robust antigen-specific cytotoxic T lymphocyte response by FMDV DNA vaccination with IL-9 expressing construct. J Biomed Biotechnol 2010;2010:562356; PMID:20445754
10. Yeh N, Glosson NL, Wang N, Guindon L, McKinley C, Hamada H, Li Q, Dutton RW, Shrikant P, Zhou B, et al. Tcl7 cells are capable of mediating immunity to vaccinia virus by acquisition of a cytotoxic phenotype. J Immunol 2010;185:2089-98; PMID:20624947; http://dx. doi.org/10.4049/j immunol. 1000818
11. + T cells (Tcl7) responses to DNA vaccination in mice. PLoS One 2011;6:e25525; PMID:21998665; http://dx.doi.org/10.1371/ journal. pone.0025525
12. Geng S, Zhong Y, Wang S, Liu H, Zou Q, Xie X, Li C, Yu Q, He Z, Wang B. Amiloride enhances antigen specific CTL by faciliting HBV DNA vaccine entry into cells. PLoS One 2012;7:e33015; PMID:22438887; http://dx. doi.org/10.1371/j o urnal. pone.0033015
13. Yang FQ, Yu YY, Wang GQ, Chen J, Li JH, Li YQ, Rao GR, Mo GY, Luo XR, Chen GM. A pilot randomized controlled trial of dual-plasmid HBV DNA vaccine mediated by in vivo electroporation in chronic hepatitis B patients under lamivudine chemotherapy. J Viral Hepat 2012;19:581-93; PMID:22762143; http://dx.doi.org/10.1111/j.1365-2893.2012.01589.x
14. Ferraro B, Morrow MP, Hutnick NA, Shin TH, Lucke CE, Weiner DB. Clinical applications of DNA vaccines: current progress. Clin Infect Dis 2011;53:296-302; PMID:21765081; http://dx.doi.org/10.1093/cid/cir334
15. Lemaire MM, Vanhaudenarde A, Nizet Y, Dumoutier L, Renauld JC. Induction of autoantibodies against mouse soluble proteins after immunization with living cells presenting the autoantigen at the cell surface in fusion with a human type 2 transmembrane protein. J Immunol Methods 2011;367:56-62; PMID:21334341; http://dx.doi.org/10.1016/], jim.2011.02.001
16. Dumoutier L, Van Roost E, Ameye G, Michaux L, Renauld JC. IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes. Genes Immun 2000;1:488-94; PMID: 11197690; http://dx.doi.org/10.103 8/sj.gene.6363716
17. Ciccia F, Guggino G, Rizzo A, Ferrante A, Raimondo S, Giardina A, Dieli F, Campisi G, Alessandro R, Triolo G. Potential involvement of IL-22 and IL-2 2-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome. Ann Rheum Dis 2012;71:295-301; PMID:21979002; http://dx.doi.org/10. 1136/ard.2011.154013
18. Nograles KE, Zaba LC, Shemer A, Fuentes-Duculan J, Cardinale I, Kikuchi T, Ramon M, Bergman R, Krueger JG, Guttman-Yassky E. IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol 2009;123:1244, e2; http://dx.doi. Org/10.1016/j.jaci.2009.03.041; PMID:19439349
19. Zenewicz LA, Flavell RA. IL-22 and inflammation: leukin' through a glass onion. Eur J Immunol 2008;38:3265-8; PMID:19016525; http://dx.doi.org/10.1002/ eji.200838655
20. Eyerich S, Wagener J, Wenzel V, Scarponi C, Pennino D, Albanesi C, Schaller M, Behrendt H, Ring J, Schmidt-Weber CB, et al. IL-22 and TNF-α represent a key cytokine combination for epidermal integrity during infection with Candida albicans. Eur J Immunol 2011;41:1894-901; PMID:21469124; http://dx.doi.org/10.1002/eji.201041197
21. Wang P, Bai F, Zenewicz LA, Dai J, Gate D, Cheng G, Yang L, Qian F, Yuan X, Montgomery RR, et al. IL-22 signaling contributes to West Nile encephalitis pathogenesis. PLoS One 2012;7:e44153; PMID:22952908; http://dx. doi.org/10.13 71/j o urnal. pone.004415 3
22. Guilloteau K, Paris I, Pedretti N, Boniface K, Juchaux F, Huguier V, Guillet G, Bernard FX, Lecron JC, Morel F. Skin Inflammation Induced by the Synergistic Action of IL-17A, IL-22, Oncostatin M, IL-1 alpha, and TNF-alpha Recapitulates Some Features of Psoriasis. J Immunol 2010; PMID:20335534; http://dx.doi.org/10.4049/j immunol.0902464
23. Boniface K, Bernard FX, Garcia M, Gurney AL, Lecron JC, Morel F. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol 2005;174:3695-702; PMID:15749908
24. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, Reinhart TA, McAllister F, Edeal J, Gaus K, et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 2008;14:275-81; PMID:18264110; http://dx.doi.org/10.1038/nml710
25. Hanash AM, Dudakov JA, Hua G, O'Connor MH, Young LF, Singer NV, West ML, Jenq RR, Holland AM, Kappel LW, et al. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Immunity 2012;37:339-50; PMID:22921121; http://dx.doi.org/10.1016/j.immuni.2012.05.028
26. Carlson MJ, West ML, Coghill JM, Panoskaltsis-Mortari A, Blazar BR, Serody JS. In vitro-differentiated TH17 cells mediate lethal acute graft-versushost disease with severe cutaneous and pulmonary pathologic manifestations. Blood 2009;113:1365-74; PMID: 18957685; http://dx.doi.org/10. 1182/blood-2008-06-162420
27. Zhang Y, Cobleigh MA, Lian JQ, Huang CX, Booth CJ, Bai XF, Robek MD. A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus. Gastroenterology 2011;141:1897-906; PM ID:21708106; http://dx.doi.org/l 0.105 3/j.gastro.2011.06.051
28. Feng D, Kong X, Weng H, Park O, Wang H, Dooley S, Gershwin ME, Gao B. Interleukin-22 promotes proliferation of liver stem/progenitor cells in mice and patients with chronic hepatitis B virus infection. Gastroenterology 2012;143:188-98, e7; PMID:22484l 19; http://dx.doi.org/l 0.105 3/j.gastro.2012.03.044
29. Cobleigh MA, Robek MD. Protective and pathological properties of IL-22 in liver disease: implications for viral hepatitis. Am J Pathol 2013;182:21-8; PMID:23159948; http://dx.doi.org/10.1016/j, ajpath.2012.08.043
30. Wolk K, Sabat R. Interleukin-22: a novel T-and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev 2006;17:367-80; PMID: 17030002; http://dx.doi.org/10.1016/]. cytogfr.2006.09.001
31. Celia M, Fuchs A, Vermi W, Facchetti F, Otero K, Lennerz JK, Doherty JM, Mills JC, Colonna M. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009;457:722-5; PMID:18978771; http://dx.doi.org/10.10 3 8/nature07537
32. Sonnenberg GF, Fouser LA, Artis D. Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at barrier surfaces. Adv Immunol 2010;107:1-29; PMID:21034969; http://dx.doi.org/10.1016/B978-0-12- 381300-8.00001-0
33. Jones BC, Logsdon NJ, Walter MR. Structure of IL-22 bound to its high-affinity IL-22R1 chain. Structure 2008;16:1333-44; PMID: 18599299; http://dx.doi.org/10.1016/j.str.2008.06.005
34. Kotenko SV, Izotova LS, Mirochnitchenko OV, Esterova E, Dickensheets H, Donnelly RP, Pestka S. Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-lORbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J Biol Chem 2001;276:2725-32; PMID:11035029; http://dx.doi.org/10. 1074/jbc. M007837200
35. Schulz SM, Kohler G, Schiitze N, Knauer J, Straubinger RK, Chackerian AA, Witte E, Wolk K, Sabat R, Iwakura Y, et al. Protective immunity to systemic infection with attenuated Salmonella enterica serovar enteritidis in the absence of IL-12 is associated with IL-23-dependent IL-22, but not IL-17. J Immunol 2008;181:7891-901; PMID:19017979
36. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R. IL-22 increases the innate immunity of tissues. Immunity 2004;21:241-54; PMID:15308104; http://dx.doi.org/10.1016/j.immuni.2004.07.007
37. Wolk K, Witte E, Wallace E, Docke WD, Kunz S, Asadullah K, Volk HD, Sterry W, Sabat R. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 2006;36:1309-23; PMID: 16619290; http://dx.doi.org/10.1002/eji.200535 503
38. Wahl C, Wegenka UM, Leithauser F, Schirmbeck R, Reimann J. IL-22-dependent attenuation of T cell-dependent (ConA) hepatitis in herpes virus entry mediator deficiency. J Immunol 2009;182:4521-8; PMID: 19342625; http://dx.doi.org/10.4049/jimmunol.0802810
39. Radaeva S, Sun R, Pan HN, Hong F, Gao B. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 2004;39:1332-42; PMID: 15122762; http://dx.doi.org/10.1002/hep. 20184
40. Xiang X, Gui H, King NJ, Cole L, Wang H, Xie Q, Bao S. IL-22 and non-ELR-CXC chemokine expression in chronic hepatitis B virus-infected liver. Immunol Cell Biol 2012;90:611-9; PMID:21946664; http://dx.doi.org/10.1038/icb. 2011.79
41. Xu M, Morishima N, Mizoguchi I, Chiba Y, Fujita K, Kuroda M, Iwakura Y, Cua DJ, Yasutomo K, Mizuguchi J, et al. Regulation of the development of acute hepatitis by IL-2 3 through IL-22 and IL-17 production. Eur J Immunol 2011;41:2828-39; PMID:2195364l; http://dx.doi.org/10.1002/eji.201141291
42. + T (Tcl7/IF N-γ) cells: a novel cytotoxic T-cell subset converted from Tcl7 cells by IL-12. Int Immunol 2011;23:751-9; PMID:22039016; http://dx.doi.org/10.1093/intimm/dxr086
43. Zhu Y, Ju S, Chen E, Dai S, Li C, Morel P, Liu L, Zhang X, Lu B. T-bet and eomesodermin are required for T cell-mediated antitumor immune responses. J Immunol 2010;185:3174-83; PMID:20713880; http://dx. doi.org/10.4049/j immunol. 1000749
44. Mazur MA, Davis CC, Szabolcs P. Ex vivo expansion and Thl/Tcl maturation of umbilical cord blood T cells by CD 3/C D2 8 costimulation. Biol Blood Marrow Transplant 2008;14:1190-6; PMID:18804050; http://dx.doi.org/10.1016/j.bbmt.2008. 07.016
45. Kleen TO, Asaad R, Landry SJ, Boehm BO, Tary-Lehmann M. Tel effector diversity shows dissociated expression of granzyme B and interferon-gamma in HIV infection. AIDS 2004;18:383-92; PMID: 15090789; http://dx.doi.org/10.1097/ 00002030-200402200-00003
46. + TCI responses. J Immunol 1997;159:6120-30; PMID:9550413
47. Nanjappa SG, Heninger E, Wiithrich M, Gasper DJ, Klein BS. Tcl7 cells mediate vaccine immunity against lethal fungal pneumonia in immune deficient hosts lacking CD4+ T cells. PLoS Pathog 2012;8:e1002771; PMID:22829762; http://dx.doi.org/10.1371/journal. ppat. 1002771
48. Hamada H, Garcia-Hernandez Mde L, Reome JB, Misra SK, Strutt TM, McKinstry KK, Cooper AM, Swain SL, Dutton RW Tcl7, a unique subset of CD 8 T cells that can protect against lethal influenza challenge. J Immunol 2009;182:3469-81; PMID: 19265125; http://dx. doi.org/10.4049/j immunol. 0801814
49. + T cell responses predict therapeutic efficacy against tumors. J Immunol 2012;189:3397-403; PMID:22914049; http://dx.doi.org/10.4049/jimmunol. 1201540
50. Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S, Pinkert CA, Brinster RL, Palmiter RD. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 1989;59:1145-56; PMID:2598264; http://dx.doi.org/10.1016/0092-8674 (89) 90770-8
51. Wang J, Zhao W, Cheng L, Guo M, Li D, Li X, Tan Y, Ma S, Li S, Yang Y, et al. CD137-mediated pathogenesis from chronic hepatitis to hepatocellular carcinoma in hepatitis B virus-transgenic mice. J Immunol 2010;185:7654-62; PMID:21059892; http://dx.doi.org/10.4049/j immunol. 1000927
52. Chisari FV, Pinkert CA, Milich DR, Filippi P, McLachlan A, Palmiter RD, Brinster RL. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science 1985;230:1157-60; PMID:3865369; http://dx.doi.org/l 0.1126/science. 3 86 5 36 9
53. Du X, Zheng G, Jin H, Kang Y, Wang J, Xiao C, Zhang S, Zhao L, Chen A, Wang B. The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination. J Gene Med 2007;9:136-46; PMID: 17310492; http://dx.doi.org/10.1002/jgm. 1004